Month: May 2025

CALGARY, Alberta, May 12, 2025 (GLOBE NEWSWIRE) — Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) (“Prospera“, “PEI” or the “Corporation“) Convertible Debt OfferingProspera Energy Inc. (“Prospera” or the “Corporation”) intends to raise up to $2,000,000 by way of non-brokered private placement. Funds will be raised by offering 12% convertible debentures with the principal amount convertible at $0.05 in the first year and $0.10 in the second year. Applicable interest will be payable in cash or shares at the Corporation’s discretion.Issuer: Prospera Energy Inc. (“Prospera” or the “Corporation”).Issue: Convertible Debenture with a two-year term.Offering Amount: $2,000,000 CAD (the “Offering”).Conversion Price: $0.05 if converted within the first year and $0.10 if converted in...

Hopewell, New Jersey, May 12, 2025 (GLOBE NEWSWIRE) — Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally administered bee venom-based toxin which potentially exhibits diverse therapeutic effects, today announced the closing of its initial public offering (the “Offering”) of 3,375,000 shares of common stock at a public offering price of $4.00 per share. The shares began trading on the NYSE American on May 9, 2025, under the symbol “APUS.”  Gross proceeds to Apimeds from the Offering were $13.5 million, before deducting underwriting discounts and commissions and other related expenses payable by the Company. In addition, the Company has granted the underwriters a 45-day option from the closing...